PETROS PHARM INC by Petros Pharmaceuticals, Inc. Financials - Benzinga

PETROS PHARM INC by Petros Pharmaceuticals, Inc.

PTPIOTCPK

Trade with Public

Trade with Public

$0.00300

-0.0634-95.48%

Last update: Aug 14, 9:30 AM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

PETROS PHARM INC by Petros Pharmaceuticals, Inc. Financials

PETROS PHARM INC by Petros Pharmaceuticals, Inc. (PTPI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings

Avi Kapoor

Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings

Avi Kapoor

US Stocks Mixed; NY State Business Activity Rises In February

Avi Kapoor

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

PRO
Petros Pharmaceuticals Q4 EPS $(2.17) Misses $(1.11) Estimate, Sales $364.25K Miss $1.55M Estimate

Petros Pharmaceuticals (NASDAQ:PTPI) reported quarterly losses of $(2.17) per share which missed the analyst consensus estimate of $(1.11) by 95.5 percent. This is a 6.9 percent decrease over losses of $(2.03) per share

Benzinga Newsdesk

Nasdaq Down 50 Points; US Home Price Index Rises In February

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.01% to 33,872.34 while the NASDAQ fell 0.45% to 11,983.04. The S&P 500, also fell, dropping, 0.36% to 4,122.01.

Lisa Levin